The problem of diabetic neuropathy has not been studied experimentally to the same extent as have other manifestations of diabetes mellitus. One reason may be that neurological symptoms have not been apparent in animals that have been made diabetic. Lukens (2) stated in his review of alloxan diabetes that nervous system lesions had not been observed. Pancreatectomized animals have been prepared in large numbers, but no mention has been made of neurological complications. Minor neurological deficit, particularly of the sensory functions, could easily have been overlooked (3).
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The data presented below demonstrate a decrease in conduction velocity under in vitro conditions in the peripheral nerves from alloxanized rats but only if these rats also become diabetic. Because of the toxic effects of alloxan, a group of pancreatectomized rats was also prepared and showed essentially the same slowing of conduction. Treatment with insulin of the animals before the experiment or addition of insulin in vitro did not restore conduction velocity to normal values.
Methods
Sprague-Dawley rats 1 were used. The rats weighed between 300 and 450 g and were over 5 months old. The animals were injected with alloxan monohydrate in citrate buffer in amounts of 40 to 50 mg per kg (4) . Litter mates were used as controls. Intravenous injection method was used, and injections were given after 18 hours of starvation. Some of the injected animals did not become diabetic. These animals were used as * Submitted for publication July 22, 1963 ; accepted August 14, 1964. Presented in part at the meeting of the American Physiological Society in September 1959 and published in abstract form (1) . The investigation was supported in part by U. S. Public Health Service research grant no. NB-02141 from the National Institute of Neurological Diseases and Blindness and in part by grant no. 200 from the National Multiple Sclerosis Society. controls of the effect of nondiabetogenic doses of alloxan on nerve conduction. Blood sugar levels were measured at weekly intervals and on the day of the experiment with the glucose oxidase method. The rats were considered to be diabetic when the fasting blood sugar exceeded 200 mg per 100 ml and glucosuria was present. In the experiments with insulin treatment 24-hour urine volumes were collected daily under toluene for 1 week (up to the day preceding the experiment) from both treatment and control groups. Glucosuria is recorded for each group of rats in grams glucose per 24 hours ± SD. The weights of the rats were checked before injection of alloxan and at the time of the experiment. To provide control for loss of body weight, a number of animals were starved on water only, and the conduction velocity of nerves from these animals was tested.
Insulin treatment was given according to two different schedules. In one group the insulin treatment was started 3 weeks after the injection of alloxan at a time when the initial hepatic and kidney damage should have disappeared. A dose of 4 U protamine zinc insulin 2 was selected on the basis of the studies of Steiner, Rauda, and Williams (5) .
In a second group of animals the insulin treatment was started on the second day after the injection of alloxan. Those animals were used in which a strongly positive test for urine sugar was obtained at that time. The treatment was then continued with 4 U per day for 40 days.
Pancreatectomy was performed essentially according to the technique described by Scow (6) but leaving some pancreatic tissue around the bile duct. The animals that developed diabetes behaved clinically in accordance with the preparation described by Treadwell and Roe (7) . The intestinal absorption difficulties were avoided, and the animals could be kept alive for 30 to 40 days without insulin. By minor variation in operative technique other rats were obtained that showed signs of a more severe and promptly developing diabetes and that could be kept alive only through the application of the Scow (6) scheme for postoperative care. These animals had to be maintained on insulin for the remainder of the experimental period and were given regular and protamine zinc insulin as needed.
The rats were fasted 18 hours before the experiment except for pancreatectomized animals on insulin and their controls. The animals were then stunned by a blow on the head and decapitated. The sciatic nerve from the sciatic notch to the gastrocnemius tendon was removed and soaked 10 minutes in Ringer-Locke buffer to eliminate spontaneous firing (8) . The nerves were then placed in a moist chamber on bridges made from silver chloride-silver electrodes or platinum wire electrodes. Temperature was kept constant by immersing the chamber in a constant temperature bath. Electrical stimulation was obtained from Grass S-4 stimulators with stimulus isolators. The stimulation intensity was kept 3 to 5 times the value necessary for maximal response. The evoked potentials were amplified and recorded with Tectronix equipment. Conduction times were measured from photographs after magnification. After the experiment the nerves were removed, and the distance from stimulating to recording electrodes was measured. Conduction velocity is given as meters per second + standard deviation. In experiments designed to study the changes in sensory versus motor nerve fibers, a preparation was obtained by rapid dissection of a dorsal and ventral root together with the sciatic nerve. The continuous structure from the ventral and dorsal root to the tibial nerve was then placed on a Y-shaped bridge so that stimulation of the ventral root and recording from the tibial nerve, as well as stimulation of the tibial nerve and recording from the dorsal root, was possible (see Figure   2 ).
In all experiments the corresponding sciatic nerve from a normal noninjected animal was treated in the same fashion as the diabetic nerve. The remaining diabetic sciatic nerve and the remaining normal nerve were used for neurochemical studies as described elsewhere (9) .
Results
The tibial nerve from which the recordings were obtained contains a number of large, myelinated fibers. The cmnduction velocity in the fastest conducting tibial nerve fibers activated on supramaximal stimulation of the sciatic nerve at the sciatic notch will be referred to as inflexion velocity (10) . It was found to be 70 4 m per second in normal rats (24 animals Three groups of diabetic rats and a control group were studied after 6 weeks in order to establish the adequacy of the insulin treatment (Table II) . Urine was collected from all four groups daily for 1 week before the determination of the conduction velocity. Two of the diabetic groups were treated with insulin. One of the groups was started on insulin on the second day after alloxan injection. The other group was started 3 weeks after injection at a time when the diabetes was well established. The insulin treatment reduced the amount of glucose in the urine sharply but had no effect on the development or magnitude of the conduction defect.
Some animals appeared severely ill during the first week after injection of alloxan. The presence of diabetic ketoacidosis was suspected and confirmed by laboratory studies. A decrease in inflexion velocity was noted already after 5 or 6 days in all diabetic animals. Because of the known occurrence of lesions of kidney and liver and the disturbances of electrolyte and acid-base balance that take place in the early stages, data obtained before 10 days were considered less unequivocal and were not tabulated. In no animal, however, could any correlation be demonstrated between the appearance and amount of ketoacidosis and conduction velocity.
Inasmuch as electrical stimulation at the sciatic notch would not distinguish between sensory and motor fibers, these two types were studied separately. The ventral root was stimulated with recording taking place at the distal portion of the tibial nerve. This was compared to stimulation of the tibial nerve and recording from the dorsal root. Figure 2 shows The time course of the observed reduction in peak conduction velocity was examined in both alloxanized and pancreatectomized groups that had not been treated with insulin. In order to avoid the period of generalized toxic effect of alloxan, only the values at 10 days and later are charted. Already at 10 days a clear reduction in peak conduction velocity can be observed (Figgure 4) . A slowly progressive decrease in conduction velocity takes place over 2 months in the alloxanized group. A continued slowing of conduction velocity is also seen between days 10 and 30 in the pancreatectomized rats.
Additional studies were made on a group of rats with more extensive removal of the pancreas. These animals had to be maintained on insulin from the first postoperative day and were limited to a food intake of not more than 10 g per day with 12 U of insulin. Normal and alloxanized diabetic animals were given the same amount of food; the latter group was given 4 U of protamine zinc insulin (see Methods). The experiment was terminated after 3 weeks. Weight changes and blood and urine sugars as well as inflexion and peak conduction velocities for the three groups are given in Table III . The addition of exogenous insulin, which made it possible for the pancreatectomized rats to maintain a modest weight gain and controlled the amount of glucosuria, was without effect on conduction velocity of the nerve just as it was ineffective in overcoming the nerve lesion in alloxan-induced diabetes.
Discussion Alloxan-induced diabetes is secondary to destruction of beta cells in the pancreas (12) . The destruction is a result of the toxic action of alloxan, but the exact mechanism remains unknown. The effect of the injected alloxan can be nullified by rapid inactivation in the blood stream, and this occurs in some animals in spite of the buffering system used at the injection. The conduction velocity defect was observed only in animals in which the effectiveness of alloxan was evidenced by the presence of a persistently elevated blood sugar, increased urine output, and glucosuria. The possibility that the nerve conduction defect was due to direct action of alloxan on the nerve conduction mechanisms was in part eliminated by the finding of normal conduction velocities in animals that had not become diabetic upon injection of equivalent amounts of alloxan per unit body weight. The fact that nerves from pancreatectomized diabetic rats have a decrease of conduction velocity comparable to that of the alloxanized rats is further evidence that the conduction deficit in the alloxanized animal is not an expression of pharmacological neurotoxicity of alloxan but rather the secondary consequence of a diabetic stage.
Biochemical studies of peripheral nerves have indicated that alloxan diabetes is associated with an impaired incorporation of acetate and glucose into nerve lipids (9, 13, 14) . Eventually this could affect the size or properties of the myelin sheath, or both. The difference between nerves from normal and diabetic rats in the conduction of nerve impulses is noted 5 to 6 days after alloxan injection, which is comparable to the biochemical defects in lipogenesis noted by Field and Adams (13) after 48 hours and by Eliasson and Hughes (9) after 1 week. The relationship between fiber diameter and conduction velocity is not exact enough to permit any conclusions as to the effect of small variations in diameter (15) . The slowing was uniform along the axon from the roots to the distal tibial nerve, and therefore neither increased branching nor degeneration with subsequent regeneration could be invoked as explanation for the decreased conduction velocity.
It seems clear from the experiments that a diabetic state induced by alloxan or pancreatectomy results in a slowing of conduction velocity. Without wishing to imply that the neural lesion of human diabetics is the same as that observed in these studies, we point out that slowing of motor fiber conduction was noted in almost all of the 103 unselected diabetic patients by Mulder, Lambert, Bastron, and Sprague (16) and in sensory nerve fibers in diabetics by Liberson (17) . A considerable number of similar observations in man are now available (18) (19) (20) (21) (22) . The nature of the factors involved in addition to carbohydrate metabolism could not be ascertained. Mayer (22) brings up the possibility of a widening of the nodes of Ranvier as an explanation for the slowing of conduction. This mechanism was originally proposed by Denny-Brown and Brenner (23, 24) to explain slowing after focal ischemia. Such a widening could also be the result of a local decrease in turnover of myelin lipids.
The lack of effect of insulin in vitro on the conduction velocity could easily be attributed to a permeability effect or to an inability of insulin to reverse instantaneously the changes wrought by a prolonged diabetic state. The lack of effect on the conduction defect of in vitro treatment with insulin is similar to the lack of effect of exogenous insulin on lipogenesis noted by Field and Adams (13) . Shichiri (14) , however, could reverse the depression of lipid synthesis from acetate and glucose caused by alloxan diabetes with exogenous insulin treatment. It 4) Nondiabetic alloxanized animals and starved rats showed no reduction in sciatic nerve conduction rates.
5) Insulin treatment of the diabetic rats or addition of insulin to the in vitro preparation did not affect the reduced conduction velocity.
